Respiratory Syncytial Virus (RSV) Explainer
Respiratory syncytial virus, usually called RSV, is a common virus that infects the respiratory tract. Many infections cause a runny nose, cough, congestion, and other cold-like symptoms. Most people recover without hospital treatment. However, RSV can cause serious illness in infants, older adults, and people with certain medical conditions. The familiar appearance of a cold does not reliably show how the illness will progress in a vulnerable person.
RSV can affect the small airways, causing bronchiolitis, or lead to pneumonia. A baby may feed less, seem unusually irritable, or become less active rather than show all the symptoms expected in an older child. Some people develop wheezing or worsening breathing difficulties. RSV can also aggravate existing lung conditions. Symptoms overlap with other respiratory infections, so a cough alone cannot identify the virus responsible.
The virus spreads through respiratory secretions, close contact, and contaminated surfaces followed by touching the face. Reinfections can happen throughout life. Staying away from others when sick, hand hygiene, cleaning frequently touched surfaces, and improving indoor air can help reduce spread. Protecting very young infants and vulnerable adults deserves particular care when someone nearby has respiratory symptoms, even if that person considers the illness minor.
Care is usually supportive, focusing on hydration, comfort, and monitoring. Severe illness may need oxygen, fluids, or other hospital support. Trouble breathing, inadequate drinking, or worsening symptoms should prompt medical advice. Severe breathing difficulty, pauses in an infant’s breathing, blue or gray lips, or inability to wake normally requires emergency help. Prevention also includes immunization options for eligible groups, with the appropriate product and timing discussed with a clinician.
Infants have small airways, so swelling and secretions can have a substantial effect on breathing and feeding. Prematurity, certain heart or lung conditions, and immune problems can increase vulnerability. Older adults and people with relevant chronic illnesses may also become seriously unwell. These risks inform monitoring and prevention, but severe illness is not inevitable for every at-risk person and mild early symptoms still need observation for change.
RSV commonly circulates alongside other respiratory viruses. In many temperate regions activity rises in colder months, but the timing varies by location and year. An article’s place in a monthly series does not indicate a current local outbreak. Healthcare services use clinical assessment and, when appropriate, testing to clarify illness. What matters immediately is how a person is breathing, drinking, and responding, rather than waiting to learn the exact virus name.
For an uncomplicated infection, fluids and suitable symptom relief can help while the body recovers. Ask a clinician or pharmacist about age-appropriate medicines and interactions. Products marketed for adult colds are not automatically appropriate for babies or children. Antiviral medicine is not routinely used for ordinary RSV infection. Someone with a significant underlying condition may need review of that condition as well as support for the new illness.
Feeding less, fewer wet diapers, increasing lethargy, or a worsening cough can be important changes in a baby. Seek prompt advice when concerned, particularly for a very young infant. Chest pulling in with breaths, long pauses, abnormal coloring, or difficulty staying awake are emergency signs. Do not delay seeking care to try another home remedy or obtain a test. In adults, severe breathlessness or confusion also warrants urgent attention.
Covering coughs and sneezes, washing hands, and keeping commonly handled surfaces clean reduce opportunities for transmission. Cleaner air, additional distancing, or masks can add protection when appropriate. People may spread RSV before recognizing symptoms, so prevention is imperfect. Families can ask sick visitors to postpone contact with a newborn or a vulnerable relative. These measures support risk reduction without assuming that ordinary social contact can be made completely infection-free.
Vaccines and preventive antibodies are different ways to reduce severe RSV illness in eligible populations. Eligibility, timing, and choice depend on age, pregnancy, health risks, and local recommendations. They are preventive measures rather than treatment for an infection already underway. A clinician can explain which option applies, including protection for an infant. Current guidance should be checked when arranging care, because programs and recommendations can change over time.
Explore more "Explainers"
Discover additional explainers across politics, science, business, technology, and other fields. Each explainer breaks down a complex idea into clear, everyday language—helping you better understand how major concepts, systems, and debates shape the world around us.